Elanco Animal Health (ELAN) director purchases 5,000 shares of stock
Rhea-AI Filing Summary
Elanco Animal Health Inc director Michael J. Harrington purchased 5,000 shares of common stock on 2026-08-12 in an open market or private transaction at a price of $21.82 per share. Following this transaction, his directly held position increased to 131,451 shares of Elanco common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,000 shares
Net Buy
1 txn
Insider
Harrington Michael J
Role
Director
Bought
5,000 shs ($109K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $21.82 | $109K |
Holdings After Transaction:
Common Stock — 131,451 shares (Direct)
Key Figures
Shares purchased: 5,000 shares
Purchase price: $21.82 per share
Holdings after transaction: 131,451 shares
3 metrics
Shares purchased
5,000 shares
Common Stock purchased on 2026-08-12
Purchase price
$21.82 per share
Price for Common Stock purchase on 2026-08-12
Holdings after transaction
131,451 shares
Total Common Stock directly owned by director after purchase
Key Terms
purchase in open market or private transaction, Common Stock, non-derivative
3 terms
purchase in open market or private transaction regulatory
"Transaction code description is purchase in open market or private transaction"
Common Stock financial
"Security title is Common Stock in the reported transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
non-derivative financial
"Transaction type is non-derivative for the Common Stock purchase"
FAQ
What insider transaction did Elanco Animal Health (ELAN) report?
Elanco Animal Health reported that director Michael J. Harrington purchased 5,000 shares of common stock. The transaction occurred on 2026-08-12 as a purchase in open market or private transaction, according to the Form 4 disclosure.
Was the Elanco (ELAN) insider trade under a Rule 10b5-1 plan?
The transaction was not reported under a Rule 10b5-1 trading plan. The filing’s related checkbox is not marked as affirmed, and no footnote indicates that the purchase was made pursuant to a pre-arranged trading plan.
What type of security did the Elanco (ELAN) director acquire?
The director acquired Common Stock of Elanco Animal Health Inc. The Form 4 specifies a non-derivative transaction involving 5,000 shares of common stock, purchased at $21.82 per share on 2026-08-12.
Is the Elanco (ELAN) insider transaction a buy or a sell?
The reported insider transaction is a buy. Director Michael J. Harrington executed a purchase of 5,000 Elanco common shares on 2026-08-12, categorized as a purchase in open market or private transaction in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
